Belite Bio (BLTE) Total Liabilities (2020 - 2025)

Belite Bio has reported Total Liabilities for 6 years, with the latest figure at $10.1 million in Q4 2025.

• For the quarter ending Q4 2025, Total Liabilities rose 59.56% year-over-year to $10.1 million; the trailing twelve-month figure through Dec 2025 stood at $10.1 million (up 59.56% YoY), and the FY2025 full-year result was $10.1 million, up 59.56% from the prior year.
• Total Liabilities for Q4 2025 stood at $10.1 million, up from $6.3 million in the prior quarter.
• The five-year high for Total Liabilities was $10.1 million in Q4 2025, with the low at $1.6 million in Q4 2021.
• Average Total Liabilities over 5 years is $5.0 million, with a median of $4.2 million recorded in 2023.
• Year-over-year, Total Liabilities sank 76.77% in 2021 and soared 69.54% in 2022.
• Tracing BLTE's Total Liabilities over 5 years: stood at $1.6 million in 2021, then surged by 69.54% to $2.8 million in 2022, then jumped by 51.91% to $4.2 million in 2023, then soared by 49.87% to $6.3 million in 2024, then soared by 59.56% to $10.1 million in 2025.
• The last three Total Liabilities figures came in at $10.1 million (Q4 2025), $6.3 million (Q4 2024), and $4.2 million (Q4 2023), per Business Quant data.

Peer Comparison